Thromboprophylaxis strategies for COVID-19 patients

被引：1
|
作者：
Porres-Aguilar, Mateo [1 ]
Perez-Nieto, Orlando R. [2 ]
Zamarrn-Lopez, Eder I. [3 ]
Namendys-Silva, Silvio A. [4 ,5 ]
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, El Paso, TX USA
[2] Hosp San Juan Rio, Unidad Cuidados Intens, Queretaro, Mexico
[3] Hosp 6, Inst Mexicano Seguro Social, Unidad Cuidados Intens, Ciudad Madero, Tamaulipas, Mexico
[4] Inst Nacl Ciencias Med Nutr Salvador Zubiran, Div Pulmonar Med Cuidados Intens & Anestesia, Mexico City, DF, Mexico
[5] Inst Nacl Cancerol, Unidad Cuidados Intens, Mexico City, DF, Mexico
来源：
ARCHIVES OF MEDICAL RESEARCH | 2022年 / 53卷 / 01期
关键词：
D O I：
10.1016/j.arcmed.2021.06.011
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：109 / 110
页数：2
相关论文
共 50 条
  • [21] Coagulation abnormalities & thromboprophylaxis in COVID-19
    Jandial, Aditya
    Gupta, Anunay
    Malviya, Amit
    Agastam, Sourabh
    Kumar, Dilip
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2021, 153 (05) : 606 - 618
  • [22] Thromboprophylaxis in COVID-19: Still in the fog?
    Jose Scolari, Mariano
    [J]. ARS PHARMACEUTICA, 2020, 61 (04) : 205 - 207
  • [23] COVID-19 VTE Champions: a supportive quality improvement programme that optimised thromboprophylaxis in patients with COVID-19
    Price, Rebecca
    Kirkham, Zoe
    Szuman, Amy
    Ahmed, Sajeel
    Macaulay, Catriona
    Talks, Kate
    Greystoke, Brigit
    Musgrave, Kathryn
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 71 - 71
  • [24] Enoxaparin for thromboprophylaxis in hospitalized COVID-19 patients: The X-COVID-19 Randomized Trial
    Morici, Nuccia
    Podda, GianMarco
    Birocchi, Simone
    Bonacchini, Luca
    Merli, Marco
    Trezzi, Michele
    Massaini, Gianluca
    Agostinis, Marco
    Carioti, Giulia
    Serino, Francesco Saverio
    Gazzaniga, Gianluca
    Barberis, Daniela
    Antolini, Laura
    Valsecchi, Maria Grazia
    Cattaneo, Marco
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2022, 52 (05)
  • [25] Thromboprophylaxis and clinical outcomes in moderate COVID-19 patients: A comparative study
    Mohamed, Asmaa S.
    Ahmad, Hosam M.
    Abdul-Raheem, Alyaa S. A.
    Kamel, Fatma M. M.
    Khames, Ali
    Mady, Ahmed F.
    [J]. RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2022, 18 (12): : 4048 - 4055
  • [26] COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?
    Raquel Ferrandis
    Juan V. Llau
    Manuel Quintana
    Pilar Sierra
    Francisco Hidalgo
    Concepción Cassinello
    Aurelio Gómez-Luque
    [J]. Critical Care, 24
  • [27] COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?
    Ferrandis, Raquel
    Llau, Juan V.
    Quintana, Manuel
    Sierra, Pilar
    Hidalgo, Francisco
    Cassinello, Concepcion
    Gomez-Luque, Aurelio
    [J]. CRITICAL CARE, 2020, 24 (01)
  • [28] Current thromboprophylaxis in urological cancer patients during COVID-19 pandemic
    Ostrowski, Adam
    Skrudlik, Piotr
    Kowalski, Filip
    Lipowski, Pawel
    Ostrowska, Magdalena
    Adamczyk, Przemyslaw
    Adamowicz, Jan
    Drewa, Tomasz
    Juszczak, Kajetan
    [J]. CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2022, 75 (02) : 128 - 134
  • [29] Pharmacologic Thromboprophylaxis and Thrombosis in Hospitalized Patients with COVID-19: A Pooled Analysis
    Patell, Rushad
    Chiasakul, Thita
    Bauer, Ethan
    Zwicker, Jeffrey, I
    [J]. THROMBOSIS AND HAEMOSTASIS, 2021, 121 (01) : 76 - 85
  • [30] Suggestions for thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19
    Alessandro, Casini
    Lorenzo, Alberio
    Anne, Angelillo-Scherrer
    Pierre, Fontana
    Bernhard, Gerber
    Lukas, Graf
    Inga, Hegemann
    Wolfang, Korte
    Kremer, Hovinga Johanna
    Thomas, Lecompte
    Maria, Martinez
    Michael, Nagler
    Jan-Dirk, Studt
    Dimitrios, Tsakiris
    Walter, Wuillemin
    Lars, Asmis M.
    [J]. SWISS MEDICAL WEEKLY, 2020, 150
12345